TCNNF
Price
$8.11
Change
-$0.89 (-9.89%)
Updated
Aug 14 closing price
Capitalization
1.45B
81 days until earnings call
TSNDF
Price
$0.82
Change
-$0.07 (-7.87%)
Updated
Aug 14 closing price
Capitalization
264.96M
94 days until earnings call
Interact to see
Advertisement

TCNNF vs TSNDF

Header iconTCNNF vs TSNDF Comparison
Open Charts TCNNF vs TSNDFBanner chart's image
Trulieve Cannabis
Price$8.11
Change-$0.89 (-9.89%)
Volume$1.24M
Capitalization1.45B
TerrAscend
Price$0.82
Change-$0.07 (-7.87%)
Volume$1.15M
Capitalization264.96M
TCNNF vs TSNDF Comparison Chart in %
Loading...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TCNNF vs. TSNDF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Hold and TSNDF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (TCNNF: $7.51 vs. TSNDF: $0.83)
Brand notoriety: TCNNF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TCNNF: 230% vs. TSNDF: 129%
Market capitalization -- TCNNF: $1.45B vs. TSNDF: $264.96M
TCNNF [@Pharmaceuticals: Generic] is valued at $1.45B. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $264.96M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileTSNDF’s FA Score has 1 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • TSNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both TCNNF and TSNDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCNNF’s TA Score shows that 4 TA indicator(s) are bullish while TSNDF’s TA Score has 3 bullish TA indicator(s).

  • TCNNF’s TA Score: 4 bullish, 4 bearish.
  • TSNDF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than TSNDF.

Price Growth

TCNNF (@Pharmaceuticals: Generic) experienced а +31.06% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was +49.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

TSNDF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCNNF($1.45B) has a higher market cap than TSNDF($265M). TCNNF YTD gains are higher at: 44.883 vs. TSNDF (27.554). TCNNF has higher annual earnings (EBITDA): 275M vs. TSNDF (9.91M). TCNNF has more cash in the bank: 328M vs. TSNDF (30.2M). TSNDF has less debt than TCNNF: TSNDF (246M) vs TCNNF (824M). TCNNF has higher revenues than TSNDF: TCNNF (1.19B) vs TSNDF (297M).
TCNNFTSNDFTCNNF / TSNDF
Capitalization1.45B265M546%
EBITDA275M9.91M2,776%
Gain YTD44.88327.554163%
P/E RatioN/A82.91-
Revenue1.19B297M400%
Total Cash328M30.2M1,086%
Total Debt824M246M335%
FUNDAMENTALS RATINGS
TCNNF vs TSNDF: Fundamental Ratings
TCNNF
TSNDF
OUTLOOK RATING
1..100
1923
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
179
SEASONALITY SCORE
1..100
550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSNDF's Valuation (79) in the null industry is in the same range as TCNNF (84). This means that TSNDF’s stock grew similarly to TCNNF’s over the last 12 months.

TSNDF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that TSNDF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's SMR Rating (94) in the null industry is in the same range as TSNDF (97). This means that TCNNF’s stock grew similarly to TSNDF’s over the last 12 months.

TCNNF's Price Growth Rating (35) in the null industry is in the same range as TSNDF (35). This means that TCNNF’s stock grew similarly to TSNDF’s over the last 12 months.

TSNDF's P/E Growth Rating (9) in the null industry is in the same range as TCNNF (17). This means that TSNDF’s stock grew similarly to TCNNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCNNFTSNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend about 1 month ago
87%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEZX16.22N/A
N/A
MM S&P 500® Index R5
JAMCX36.25N/A
N/A
JPMorgan Mid Cap Value A
BFONX21.87N/A
N/A
Biondo Focus Investor
HWVAX12.12N/A
N/A
Hotchkis & Wiley Sm Cp Divers Val A
DESRX24.87N/A
N/A
DWS ESG Core Equity R

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
-7.35%
GTBIF - TCNNF
83%
Closely correlated
-12.40%
CURLF - TCNNF
80%
Closely correlated
-9.48%
VRNOF - TCNNF
76%
Closely correlated
-19.33%
TSNDF - TCNNF
76%
Closely correlated
+1.10%
CRLBF - TCNNF
75%
Closely correlated
-1.25%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
+1.10%
GTBIF - TSNDF
78%
Closely correlated
-12.40%
CRLBF - TSNDF
76%
Closely correlated
-1.25%
TCNNF - TSNDF
76%
Closely correlated
-7.35%
CURLF - TSNDF
74%
Closely correlated
-9.48%
VRNOF - TSNDF
74%
Closely correlated
-19.33%
More